This Brown & Brown Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Morgan Stanley analyst Bob Huang downgraded the rating for Brown & Brown, Inc. BRO from Overweight to Equal-Weight and maintained the price target of $128. Brown & Brown shares closed at $120.98 on Monday. See how other analysts view this stock.
Jefferies analyst Surinder Thind downgraded Dun & Bradstreet Holdings, Inc. DNB from Buy to Hold and cut the price target from $11 to $9.15. Dun & Bradstreet shares closed at $8.99 on Monday. See how other analysts view this stock.
Leerink Partners analyst Marc Goodman downgraded Opthea Limited OPT from Outperform to Market Perform and lowered the price target from $12 to $1. Opthea shares closed at $3.36 on Monday. See how other analysts view this stock.
Citigroup analyst Anthony Pettinari downgraded the rating for The AZEK Company Inc. AZEK from Buy to Neutral and lowered the price target from $61 to $51.5. AZEK shares closed at $48.56 on Monday. See how other analysts view this stock.
Stephens & Co. analyst Mason Carrico downgraded Akoya Biosciences, Inc. AKYA from Overweight to Equal-Weight and slashed the price target from $3.5 to $1.8. Akoya Biosciences shares closed at $1.67 on Monday. See how other analysts view this stock.